SCHEMBL18342012

SCHEMBL18342012

N#Cc1cc(-c2ccc(F)cc2)oc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
MAPT P10636 4/20 0.40
KDM4E B2RXH2 4/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
PKM P14618 2/20 0.40
ATM Q13315 2/20 0.40
GLA P06280 2/20 0.40
GAA P10253 2/20 0.40
ALOX12 P18054 1/20 0.40
HTT P42858 1/20 0.40
CSNK2A1 P68400 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
MAOB P27338 3/20 0.39
ESR1 P03372 2/20 0.39
ESR2 Q92731 2/20 0.39
MAOA P21397 2/20 0.39
GABRP O00591 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6415752 0.83 KDM4E (0.43) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL26104293 0.83 MAOB (0.41) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL1789380 0.82 MEN1 (0.50) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL4829289 0.79 KDM4E (0.51) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL27854213 0.71 MAOA (0.40) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL5635202 0.71 CYP11B2 (0.45) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL12733363 0.69 CYP11B2 (0.54) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL3574934 0.69 CYP11B1 (0.50) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL18341896 0.69 ALDH1A1 (0.51) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL2959360 0.67 CYP11B1 (0.44) ALDH1A1MAPTKDM4EHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115011090-A Degradable material and preparation method and application thereof 万华化学(宁波)有限公司 2022-09-06 CN claimed
CN-115011090-B Degradable material and preparation method and application thereof 万华化学(宁波)有限公司 2024-02-02 CN disclosed
CN-115011090-A Degradable material and preparation method and application thereof 万华化学(宁波)有限公司 2022-09-06 CN disclosed
CN-108137497-B Bicyclic derivatives, process for their preparation and pharmaceutical compositions containing them 法国施维雅药厂 2021-06-15 CN disclosed
EP-3313817-B1 BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SERVIER LAB (FR) 2020-09-16 EP disclosed
US-10618909-B2 Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2020-04-14 US disclosed
US-20190248805-A1 BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2019-08-15 US disclosed
US-10323041-B2 Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2019-06-18 US disclosed
US-20180258098-A1 BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2018-09-13 US disclosed
EP-3313817-A1 NEW BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Les Laboratoires Servier (FR) 2018-05-02 EP disclosed
WO-2016207217-A1 NEW BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2016-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10618909-B2 Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them BAX, CASP3, CASP4 ALDH1A1 2683/4885MAPT 2492/4885KDM4E 2880/4885
US-20180258098-A1 BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BAX, CASP3, CASP4 ALDH1A1 2755/4885MAPT 2516/4885KDM4E 2913/4885
US-20190248805-A1 BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BAX, CASP3, CASP4 ALDH1A1 2683/4885MAPT 2492/4885KDM4E 2880/4885
US-10323041-B2 Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them BAX, CASP3, CASP4 ALDH1A1 2683/4885MAPT 2492/4885KDM4E 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.